Skip to main content
. 2022 Jul 31;15(10):2458–2467. doi: 10.1111/cts.13374

TABLE 2.

Summary of PK parameters of RD12014 and Victoza

PK parameter arithmetic mean (SD) [CV%] RD12014 (n = 49) Victoza (n = 49)
C max (ng/ml) 42.11 (9.868) [23.43] 37.58 (9.025) [24.01]
AUC0−last (h*ng/ml) 1084.8130 (225.2798) [20.77] 967.8264 (183.0252) [18.91]
AUC0−inf (h*ng/ml) 1103.7647 (225.1409) [20.40] 990.1840 (181.6512) [18.35]
T max (h) 11 (8–14.017) 11 (8–24)
t 1/2 (h) 9.8677 (1.2213) [12.38] 10.3209 (1.8196) [17.63]
CL/F (ml/h) 567.7798 (126.3296) [22.25] 626.3771 (116.5173) [18.60]
V d/F (ml) 8060.3928 (1978.2818) [24.54] 9363.2055 (2624.9996) [28.04]
λ z (1/h) 0.0713 (0.0090) [12.63] 0.0689 (0.0103) [14.94]

Note: Data are presented as arithmetic mean (SD) [CV%] except T max are presented as median (minimum‐maximum).

Abbreviations: AUC0−last, area under the concentration‐time curve from time 0 to the time of the last quantifiable concentration; AUC0−inf, area under the concentration‐time curve from time 0 to infinity; CL/F, apparent total oral clearance; C max, maximum plasma concentration; h, hour; ml, milliliter; ng, nanogram; PK, pharmacokinetic; SD, standard deviation; t 1/2, elimination half‐life time; T max, time to maximum plasma concentration; V d/F, apparent volume of distribution based on the terminal phase; λ z, elimination rate constant.